Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :42
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Phase 1 dose escalation study of rigosertib by 2-, 4-, or 8-hour infusion twice-weekly in patients with advanced cancer

Advani S H, Achrekar S D, Doval D C, Raghunadharao D, Wilhelm F E, Acharya M

Year : 2014| Volume: 51| Issue : 1 | Page no: 40-44

   This article has been cited by
 
1 Targeting mitosis exit: A brake for cancer cell proliferation
Xinran Liu,Yuchen Chen,Yangkai Li,Robert B. Petersen,Kun Huang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2019; 1871(1): 179
[Pubmed]  [Google Scholar] [DOI]
2 Targeting polo-like kinase 1 in acute myeloid leukemia
Joseph M. Brandwein
Therapeutic Advances in Hematology. 2015; 6(2): 80
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow